| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2024-03-01 |
DNASense
Life Science Aalborg, Denmark www.dnasense.com DNASense is a microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics. DNASense was founded in 2014 and is based in Aalborg, Denmark. |
Add-on Acquisition |
Clinical Microbiomics
|
- | ||
| Deal Article Deal Link | ||||||
| 2023-08-30 |
Embark Biotech
Life Science Denmark www.embarkbiotech.com Embark Biotech is a research and development collaboration to discover and develop novel pharmaceuticals to treat obesity and related co-morbidities. |
Add-on Acquisition |
Novo Nordisk
|
- | ||
| Deal Article Deal Link | ||||||
| 2023-01-05 |
Twelve Bio
Life Science Copenhagen, Denmark www.twelve.bio Twelve Bio is a gene editing company pioneering the therapeutic application of next-generation CRISPR-Cas technology. The company has advanced foundational insights from X-ray crystallography and cryogenic electron microscopy to further engineer and evolve CRISPR-Cas12a into wholly novel sequences with unique properties useful for a range of DNA editing strategies. Twelve Bio was formed in 2019 and is based in Copenhagen, Denmark. |
Add-on Acquisition |
Ensoma
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-10-17 |
MS-Omics
Life Science Vedbæk, Denmark www.msomics.com MS-Omics is a service provider of metabolomics and data analysis that supports your analysis needs, from small to large studies. MS-Omics was founded in 2014 and is based in Vedbæk, Denmark. |
Add-on Acquisition |
Clinical Microbiomics
|
- | ||
| 2022-05-04 |
Intomics
Life Science Copenhagen, Denmark www.intomics.com Intomics is a bioinformatics and systems biology company that accelerates and optimizes pharmaceutical drug discovery and development by enabling complex analysis of biomedical data. Intomics was founded in 2008 and is based in Copenhagen, Denmark. |
Add-on Acquisition |
ZS Associates, Inc.
|
- | ||
| Deal Article Deal Link | ||||||
| 2021-07-01 |
Fertin
Life Science Vejle, Denmark www.fertin.com Fertin develops and manufactures pharmaceutical and nutraceutical products for leading global companies to support healthier living. Fertin’s product portfolio has a broad variety of current and possible application areas including Nicotine Replacement Therapy, oral care, gastrointestinal, pain and allergy management, cough and cold, and much more. Fertin was founded in 1915 and is based in Vejle, Denmark. |
Add-on Acquisition
|
Philip Morris International
|
EQT
Bagger-Sorensen Group
|
||
| Deal Article Deal Link | ||||||
| 2020-06-04 |
Symphogen AS
Life Science Ballerup, Denmark www.symphogen.com Symphogen AS is a polyclonal antibody technology that provides a totally new, innovative class of biopharmaceuticals for treating serious human diseases. Symphogen was founded in 2000 and is based in Ballerup, Denmark. |
Add-on Acquisition |
Servier
|
EW Healthcare Partners
Gilde Healthcare
|
||
| Deal Article Deal Link | ||||||
| 2020-03-24 |
Azanta A/S
Life Science Valby, Denmark www.azanta.com Azanta A/S is a privately-owned specialty pharma company primarily operating within oncology, women's health and addiction medicine. Azanta A/S currently markets (or makes available under special authorization) a portfolio of specialty pharmaceutical products, including Nimorazole a hypoxic radiosensitizer for the treatment of head and neck cancer patients undergoing primary radiotherapy and Angusta® for labor induction. |
Add-on Acquisition |
Norgine
|
EEP Advisers
|
||
| Deal Article Deal Link | ||||||
| 2017-12-22 |
BioCare Copenhagen A/S
Life Science Copenhagen, Denmark www.biocarecph.com BioCare Copenhagen A/S is a provider of probiotics and specialized in microbial actives with proven health benefits, targeting gastrointestinal disorders, metabolic disorders, infections, and immunity. BioCare Copenhagen A/S was established in 2012 and is based in Copenhagen, Denmark. |
Add-on Acquisition |
DSM-Firmenich
|
- | ||
| Deal Article Deal Link | ||||||
| 2017-03-24 |
VBM Laboratoriet A/S
Life Science Aabybro, Denmark www.vbmlab.dk VBM Laboratoriet A/S is a developer of an environment testing laboratories in the country, with a strong reputation for testing of contaminated soil and building materials particularly within the construction sector. |
Add-on Acquisition |
Eurofins Scientific
|
- | ||
| Deal Article Deal Link | ||||||
| 2016-12-20 |
AGC Biologics
Life Science Bothell, Denmark www.agcbio.com AGC Biologics is a global contract manufacturing and development (CDMO) company for biopharmaceuticals. AGC Biologics is based in Bothell, Washington. |
Add-on Acquisition
|
AGC
|
Monitor Clipper Partners
EEP Advisers
|
||
| Deal Link | ||||||
| 2016-06-21 |
Serendex Pharmaceuticals A/S
Life Science Horsholm, Denmark www.serendex.com Serendex Pharmaceuticals A/S is a developer of novel inhalation therapies for the treatment of patients with rare respiratory conditions. |
Add-on Acquisition |
Savara Pharmaceuticals
|
- | ||
| Deal Article Deal Link | ||||||
| 2015-05-06 |
Epitherapeutics ApS
Life Science Kobenhavn N, Denmark Epitherapeutics ApS is a developer of novel innovative cancer drugs based on epigenetics. |
Add-on Acquisition
|
Gilead Sciences
|
- | ||
| Deal Article Deal Link | ||||||
| 2014-11-28 |
Contera Pharma ApS
Life Science Copenhagen, Denmark www.bukwang.co.kr Contera Pharma ApS is involved in identifying and developing treatments for patients suffering from movement disorders. |
Add-on Acquisition |
Bukwang Pharmaceutical
|
- | ||
| Deal Article Deal Link | ||||||
| 2014-11-03 |
Galecto
Life Science Copenhagen, Denmark www.galecto.com Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets that are at the heart of fibrosis, inflammation, and cancer. Galecto was formed in 2011 and is based in Copenhagen, Denmark. |
Add-on Acquisition |
Bristol-Myers Squibb
|
- | ||
| Deal Article Deal Link | ||||||
| 2014-08-06 |
Santaris Pharma A/S
Life Science Horsholm, Denmark www.santaris.com Santaris Pharma A/S is developing a diverse pipeline of LNA therapeutics that influence the production or activity of select RNA targets to address diseases that are difficult-to-treat with conventional drug modalities. Santaris uses its proprietary Locked Nucleic Acid (LNA) platform and tissue-targeting expertise to pioneer next-generation antisense product candidates. |
Add-on Acquisition
|
Roche
|
Gilde Healthcare
|
||
| Deal Article Deal Link | ||||||
| Avg |
$571
0.0x EBITDA 0.0x REVENUE |
|||||
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.